Abstract
Managing quality control (QC)/quality assurance (QA) is a challenge in biopharmaceutical manufacture and product release. While many of the quality systems which are applied to biopharmaceutical products are also employed in the control of chemical pharmaceutical products and traditional biological products, there are special QC/QA concerns associated with the control of biopharmaceutical products. The main component that is used in the production process is a living organism which has been genetically altered. The manufacturing processes used to produce biopharmaceuticals, whether recombinant DNA methods or hybridoma technologies, can be fairly complicated with extended production times. Adequate in-process testing, thorough process validation, and a comprehensive assessment of final product quality using a complete battery of analytical methodologies, is needed to demonstrate lot-to-lot consistency. How a biopharmaceutical company that is not a fully integrated pharmaceutical company, but instead either...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
